What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
admin Get ready for a big change in how the U.S. will pay for COVID-19 vaccines…
Read MoreBioNTech SE ADR
Large-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
People who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions…
Read MoreU.K. regulator is first to authorize Moderna’s bivalent COVID booster for 18-and-older population
The U.K. regulator has become the first to authorize Moderna’s bivalent COVID vaccine booster for…
Read MoreOfficial U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read MoreOfficial U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read MoreModerna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
Moderna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for the…
Read MoreResearch shows coronavirus pandemic originated in Wuhan wet market and did not escape from a Chinese lab
Research published Tuesday by the journal Science offers more evidence that the coronavirus pandemic that…
Read MoreResearch shows coronavirus pandemic originated in Wuhan wet market and did not escape from a Chinese lab
Research published Tuesday by the journal Science offers more evidence that the coronavirus pandemic that…
Read MoreNovavax’s protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read More
Get ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is…
Read More